0001325812-15-000052.txt : 20150618 0001325812-15-000052.hdr.sgml : 20150618 20150618163837 ACCESSION NUMBER: 0001325812-15-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150616 FILED AS OF DATE: 20150618 DATE AS OF CHANGE: 20150618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vaishnaw Akshay CENTRAL INDEX KEY: 0001458494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 15940538 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-06-16 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001458494 Vaishnaw Akshay 300 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 EVP, R&D, CMO Common Stock 2015-06-16 4 M 0 6250 9.3 A 6250 D Common Stock 2015-06-16 4 M 0 2500 7.1 A 8750 D Common Stock 2015-06-16 4 S 0 3933 128.0983 D 4817 D Common Stock 2015-06-16 4 S 0 2667 128.7885 D 2150 D Common Stock 2015-06-16 4 S 0 1800 130.0554 D 350 D Common Stock 2015-06-16 4 S 0 350 130.9986 D 0 D Common Stock 103 I by Managed Account Stock Option (right to buy) 7.1 2015-06-16 4 M 0 2500 0 D 2021-11-30 Common Stock 2500 5000 D Stock Option (right to buy) 9.3 2015-06-16 4 M 0 6250 0 D 2021-06-09 Common Stock 6250 0 D The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2013 Sale prices ranged from $127.49 to $128.46. Sale prices ranged from $128.49 to $129.38. Sale prices ranged from $129.55 to $130.50. Sale prices ranged from $130.57 to $131.22. The reporting person owns 103 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. /s/ Michael P. Mason, Attorney-in-Fact for Akshay K. Vaishnaw 2015-06-18